Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes

Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes

US Patent 7875275 · Granted Jan 25, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of using a GIP/GLP1 co-agonist for therapy2025
Chimeric receptors to DLL3 and methods of use thereof2024
Method of screening for colorectal cancer2021
Methods of treatment using a pentapeptide derived from the C-Terminus of Glucago2018
C-terminal fragments of glucagon-like peptide-1 (GLP-1)2018
Methods for treating steatotic disease2015
C-terminal fragments of glucagon-like peptide-1 (GLP-1)2014
Stem cells of the islets of langerhans and their use in treating diabetes mellit2012
Stem cells of the islets of langerhans and their use in treating diabetes mellit2012
Methods to stimulate insulin production by pancreatic β-cells2009
Methods to stimulate insulin production by pancreatic β-cells2009
Stem cells of the islets of Langerhans and their use in treating diabetes mellit2009